Biologic Therapy
Biologic Therapy for Psoriasis
Biologic Therapies
Conventional (Nonbiologic) Therapy
Omalizumab leads biologics in reducing exacerbations in severe asthma
SAN DIEGO — Patients with severe asthma experienced fewer exacerbations with 6 months of treatments with biologics, according to a study presented at the American Thoracic Society International Conference.
Biologic Therapy
Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes
Bimekizumab treatment for psoriatic arthritis demonstrated rapid, clinically meaningful improvements to patient reported outcomes that were sustained up to 1 year, according to data published in Rheumatology.
Biologics therapy may lead to greater asthma remission in non-white patients
SAN DIEGO — Asthma remission may occur more often with the use of biologics, but non-white patients receive fewer biologics than white patients, according to an abstract presented at the American Thoracic Society International Conference.
Osteochondral allograft had similar results as cell-based therapy for cartilage lesions
Published results showed osteochondral allograft transplantation, autologous chondrocyte implantation and matrix-induced autologous chondrocyte implantation all yielded similar outcomes for patients with patellofemoral cartilage defects.
‘Earlier use of biologics’ like belimumab may improve long-term lupus outcomes
Early use of biologics like belimumab may limit complications associated with steroid use and improve long-term outcomes in systemic lupus erythematosus, according to data presented at the EULAR 2024 Congress.
Biologics lower exacerbations, hospitalizations in COPD, Th2 inflammation
SAN DIEGO — After 1 year of biologic therapy, patients with COPD and Th2 inflammation experienced fewer exacerbations and hospitalizations, according to research presented at the American Thoracic Society International Conference.